loadpatents
Patent applications and USPTO patent grants for Kikly; Kristine Kay.The latest application filed is for "pan-elr+ cxc chemokine antibodies for the treatment of hidradenitis suppurativa".
Patent | Date |
---|---|
Pan-elr+ Cxc Chemokine Antibodies For The Treatment Of Hidradenitis Suppurativa App 20210340244 - Kikly; Kristine Kay ;   et al. | 2021-11-04 |
Pan-ELR+ CXC chemokine antibodies Grant 10,858,425 - Beidler , et al. December 8, 2 | 2020-12-08 |
Pan-ELR+ CXC CHEMOKINE ANTIBODIES App 20180362631 - Beidler; Catherine Brautigam ;   et al. | 2018-12-20 |
Pan-ELR+ CXC chemokine antibodies Grant 10,093,727 - Beidler , et al. October 9, 2 | 2018-10-09 |
Anti-CD20- / anti-BAFF bispecific antibodies Grant 9,951,146 - Allan , et al. April 24, 2 | 2018-04-24 |
Pan-ELR+ CXC CHEMOKINE ANTIBODIES App 20170362315 - Beidler; Catherine Brautigam ;   et al. | 2017-12-21 |
Pan-ELR.sup.+ CXC chemokine antibodies Grant 9,783,605 - Beidler , et al. October 10, 2 | 2017-10-10 |
Antibodies That Bind Il-23 App 20170275356 - Beidler; Catherine Brautigam ;   et al. | 2017-09-28 |
Nucleic acids encoding antibodies that bind IL-23 Grant 9,688,753 - Beidler , et al. June 27, 2 | 2017-06-27 |
Anti-cd20- / Anti-baff Bispecific Antibodies App 20160289342 - Allan; Barrett ;   et al. | 2016-10-06 |
Pan-elr+ Cxc Chemokine Antibodies App 20160152699 - Beidler; Catherine Brautigam ;   et al. | 2016-06-02 |
Pan-ELR+ CXC Chemokine Antibodies Grant 9,290,570 - Beidler , et al. March 22, 2 | 2016-03-22 |
Antibodies That Bind Il-23 App 20150232552 - Beidler; Catherine Brautigam ;   et al. | 2015-08-20 |
Antibodies that bind to IL-23 Grant 9,023,358 - Beidler , et al. May 5, 2 | 2015-05-05 |
Pan-ELR+ CXC CHEMOKINE ANTIBODIES App 20140271647 - Beidler; Catherine Brautigam ;   et al. | 2014-09-18 |
Antibodies That Bind To Il-23 App 20140255422 - BEIDLER; CATHERINE BRAUTIGAM ;   et al. | 2014-09-11 |
METHOD TO TREAT USING ANTAGONISTIC ANTI-hTNFSF13B HUMAN ANTIBODIES App 20120195904 - Kikly; Kristine Kay | 2012-08-02 |
Methods of use of sialoadhesin factor-2 antibodies Grant 8,197,811 - Abrahamson , et al. June 12, 2 | 2012-06-12 |
Method to treat using antagonistic anti-hTNFSF13b human antibodies Grant 8,173,124 - Kikly May 8, 2 | 2012-05-08 |
Anti-IL-23 antibodies Grant 7,872,102 - Beidler , et al. January 18, 2 | 2011-01-18 |
METHOD TO TREAT USING ANTAGONISTIC ANTI-hTNFSF13B HUMAN ANTIBODIES App 20100272735 - KIKLY; Kristine Kay | 2010-10-28 |
Antagonistic anti-hTNFSF13b human antibodies Grant 7,728,109 - Kikly June 1, 2 | 2010-06-01 |
Anti-IL-23 Antibodies App 20090240036 - Beidler; Catherine Brautigam ;   et al. | 2009-09-24 |
Desacyl Ghrelin Antibodies And Therapeutic Uses Thereof App 20090060920 - Witcher; Derrick Ryan ;   et al. | 2009-03-05 |
Antagonistic anti-hTNFSF13b human antibodies Grant 7,317,089 - Kikly January 8, 2 | 2008-01-08 |
Anti-Ghrelin Antibodies App 20070237775 - Kikly; Kristine Kay ;   et al. | 2007-10-11 |
Anti-myostatin antibodies App 20070178095 - Smith; Rosamund Carol ;   et al. | 2007-08-02 |
Anti-ghrelin antibodies App 20060233788 - Heiman; Mark Louis ;   et al. | 2006-10-19 |
Sialoadhesin factor-3 antibodies App 20060073133 - Kikly; Kristine Kay ;   et al. | 2006-04-06 |
Antagonistic anti-htnfsf13b human antibodies App 20050070694 - Gelfanova, Valentina Pavlovna ;   et al. | 2005-03-31 |
Therapeutic methods of use for lp229 App 20040072745 - Heuer, Josef Georg ;   et al. | 2004-04-15 |
Hnovilr App 20010025022 - Kikly, Kristine Kay ;   et al. | 2001-09-27 |
Secreted cysteine rich protein-6 (SCRP-6); polynucleotides and processes for producing polypeptides App 20010011077 - Albone, Earl Francis ;   et al. | 2001-08-02 |
Polynucleotides encoding a sialoadhesin family member-2 (SAF-2) Grant 6,146,845 - Kikly , et al. November 14, 2 | 2000-11-14 |
Sialoadhesin Family Member-3 Grant 6,090,582 - Kikly , et al. July 18, 2 | 2000-07-18 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.